🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas Huber

Novartis (China)

ORCID: 0000-0002-1844-262X

Also affiliated with Rockefeller University

Biochemistry, Genetics and Molecular BiologyMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling.

50 citations

Mizuho Horioka, Jordan M. Mattheisen, Tyler D. Hitchman, Amanda R. Moore, Manija A. Kazmi +5 more

N/A
0DataRank · unranked
17 citations

Emilie Ceraudo, Emily Lorenzen, Thomas P. Sakmar, Thomas Huber, Mizuho Horioka

1 citations

Kathryn M. Gunnison, Manija A. Kazmi, Thomas P. Sakmar, Thomas Huber, He Tian

11 citations

Kathryn M. Gunnison, Manija A. Kazmi, Thomas P. Sakmar, Thomas Huber, He Tian

13 citations

Emilie Ceraudo, Kevin Kemelmakher-Liben, Deena A. Oren, Emily Lorenzen, Tea Dodig‐Crnković +5 more

0 citations

Thomas Huber, Lauren E. Thaller, Andrey V. Struts, E. Cheng, Zachary Bachler +4 more